BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1311687)

  • 21. Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus.
    Kaufman MJ; Hartig PR; Hoffman BJ
    J Neurochem; 1995 Jan; 64(1):199-205. PubMed ID: 7798914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the contractile serotonergic receptor in guinea pig trachea with agonists and antagonists.
    Watts SW; Cohen ML
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1101-6. PubMed ID: 1312158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of brainstem 5-HT1C receptors by serotonergic drugs in the rat.
    Pranzatelli MR; Tailor PT
    Gen Pharmacol; 1994 Oct; 25(6):1279-84. PubMed ID: 7875557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
    Sanders-Bush E; Breeding M
    J Pharmacol Exp Ther; 1988 Oct; 247(1):169-73. PubMed ID: 3139864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
    Pranzatelli MR; Murthy JN; Pluchino RS
    J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
    Sheldon PW; Aghajanian GK
    Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo determination of 5-hydroxytryptamine receptor-stimulated phosphoinositide turnover in rat brain.
    Hide I; Kato T; Yamawaki S
    J Neurochem; 1989 Aug; 53(2):556-60. PubMed ID: 2545822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine.
    Kuoppamäki M; Pälvimäki EP; Syvälahti E; Hietala J
    Eur J Pharmacol; 1994 Apr; 255(1-3):91-7. PubMed ID: 8026557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of regulation of phosphoinositide metabolism by recombinant 5-HT2 receptors of the rat.
    Apud JA; Grayson DR; De Erausquin E; Costa E
    Neuropharmacology; 1992 Jan; 31(1):1-8. PubMed ID: 1311807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.
    Hoyer D; Pazos A; Probst A; Palacios JM
    Brain Res; 1986 Jun; 376(1):97-107. PubMed ID: 2941113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site.
    Conn PJ; Sanders-Bush E
    J Neurosci; 1986 Dec; 6(12):3669-75. PubMed ID: 3025382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
    Kennett GA; Curzon G
    Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus.
    Brown AM; Patch TL; Kaumann AJ
    Br J Pharmacol; 1991 Sep; 104(1):45-8. PubMed ID: 1786517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.
    Jenck F; Broekkamp CL; Van Delft AM
    Psychopharmacology (Berl); 1990; 100(3):372-6. PubMed ID: 2107558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of chronic ritanserin and clorgyline administration on 5-HT2 receptor linked inositol phospholipid hydrolysis.
    Twist EC; Brammer MJ; Stephenson JD; Corn TH; Campbell IC
    Biochem Pharmacol; 1990 Nov; 40(9):2111-6. PubMed ID: 2122900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characteristics and regulation of 5-HT receptor-stimulated phosphoinositide hydrolysis in the rat spinal cord.
    Toscano E; Romero G; Oset C; Del Río J
    Gen Pharmacol; 1999 Mar; 32(3):351-8. PubMed ID: 10211591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.
    Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1990; 42(1):13-7. PubMed ID: 2281017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.